Dietary Supplement
Oral glucose
Oral glucose is a dietary supplement with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
5
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Other(2)
Detailed Status
Completed2
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
completed240%
unknown240%
recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingnot_applicable
Effects of Acute Sugar Intake on Choroidal Thickness
NCT07376005
completednot_applicable
Effects of Oral vs Intravenous Glucose Administration on Novel Candidates of Energy Regulation
NCT04888325
completednot_applicable
Dumping Syndrome After Operation of Esophageal Atresia Type III
NCT02525705
unknownnot_applicable
Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176760
unknownnot_applicable
Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion
NCT01176708
Clinical Trials (5)
Showing 5 of 5 trials
NCT07376005Not Applicable
Effects of Acute Sugar Intake on Choroidal Thickness
NCT04888325Not Applicable
Effects of Oral vs Intravenous Glucose Administration on Novel Candidates of Energy Regulation
NCT02525705Not Applicable
Dumping Syndrome After Operation of Esophageal Atresia Type III
NCT01176760Not Applicable
Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176708Not Applicable
Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion
All 5 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 5